Key issues for stakeholder engagement in the development of health and healthcare guidelines

Established in 2015, the Multi-Stakeholder Engagement (MuSE) Consortium is an international network of over 120 individuals interested in stakeholder engagement in research and guidelines. The MuSE group is developing guidance for stakeholder engagement in the development of health and healthcare gu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research involvement and engagement 2023-04, Vol.9 (1), p.27-27, Article 27
Hauptverfasser: Petkovic, Jennifer, Magwood, Olivia, Lytvyn, Lyubov, Khabsa, Joanne, Concannon, Thomas W, Welch, Vivian, Todhunter-Brown, Alex, Palm, Marisha E, Akl, Elie A, Mbuagbaw, Lawrence, Arayssi, Thurayya, Avey, Marc T, Marusic, Ana, Morley, Richard, Saginur, Michael, Slingers, Nevilene, Texeira, Ligia, Ben Brahem, Asma, Bhaumik, Soumyadeep, Bou Akl, Imad, Crowe, Sally, Dormer, Laura, Ekanem, Comfort, Lang, Eddy, Kianzad, Behrang, Kuchenmüller, Tanja, Moja, Lorenzo, Pottie, Kevin, Schünemann, Holger, Tugwell, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Established in 2015, the Multi-Stakeholder Engagement (MuSE) Consortium is an international network of over 120 individuals interested in stakeholder engagement in research and guidelines. The MuSE group is developing guidance for stakeholder engagement in the development of health and healthcare guideline development. The development of this guidance has included multiple meetings with stakeholders, including patients, payers/purchasers of health services, peer review editors, policymakers, program managers, providers, principal investigators, product makers, the public, and purchasers of health services and has identified a number of key issues. These include: (1) Definitions, roles, and settings (2) Stakeholder identification and selection (3) Levels of engagement, (4) Evaluation of engagement, (5) Documentation and transparency, and (6) Conflict of interest management. In this paper, we discuss these issues and our plan to develop guidance to facilitate stakeholder engagement in all stages of the development of health and healthcare guideline development.
ISSN:2056-7529
2056-7529
DOI:10.1186/s40900-023-00433-6